Prostagorx 2021
Natural health product licensed in Canada
- Other names
- Prostagorx
- Licence holder
- Innovus Pharmaceuticals, Inc.
- NPN or DIN-HM
- 80113657
- Status
- Inactive licence
- Licence date
- 24 October 2021
- Revision date
- 17 August 2022
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Panax ginseng Source : Radicelles Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 500 mg | 10 mg | Not calculated |
| Panax ginseng Source : Racine Extract : Matériel brut sec Extraction ratio : 50:1 Dry plant equivalent : 500 mg | 10 mg | Not calculated |
| Piper nigrum Source : Fruit | 20 mg | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2.5 g | 250 mg | Not calculated |
| Serenoa repens Source : Fruit | 160 mg | Not calculated |
| Stérols végétaux libres Source : Helianthus annuus - Graine Potency : 100 % beta-Sitosterol | 200 mg | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 100 % beta-Sitosterol | 200 mg | Not calculated |
| Stérols végétaux libres Source : Brassica napus - entier Potency : 100 % beta-Sitosterol | 200 mg | Not calculated |
| Cucurbita pepo Source : Graine | 50 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 100 mg | 10 mg | Not calculated |
| Secale cereale Source : Pollen Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2.52 g | 252 mg | Not calculated |
Non-medicinal ingredients
Eau, Cellulose microcristalline, Farine de Glycine Soja (Fève soja), Stéarate de magnésium, Hypromellose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow/ incomplete voiding/frequent daytime/night time urination) associated with mild to moderate benign prostatic hyperplasia (BPH). Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80113657
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging